Construct Validity and Responsiveness of EQ-5D-3L in Patients With Rheumatic Disease

CompletedOBSERVATIONAL
Enrollment

77,651

Participants

Timeline

Start Date

August 16, 2024

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2024

Conditions
Rheumatoid ArthritisPolyarthritisPsoriatic ArthritisAnkylosing SpondylitisRheumatic Diseases
Interventions
OTHER

Questionnaire

In the study, the validity and responsiveness of EQ-5D-3L will be assessed. The EQ-5D-3L measures HRQoL and consists of two parts. The first part contains five questions about mobility, daily activities, self-care, pain/discomfort, and anxiety/depression (EuroQoL 1990, Brooks 1996). Each question can be answered with no problem (1), some/moderate problem (2) unable to perform certain activities/having extreme problems (3). The answers can be summarized in an index value based on an existing preference-based value set. In this study, the EQ-5D-3L value set by Dolan (Dolan 1997) will be used for the main analyses and a Swedish experience-based value set in a sensitivity analysis (Burström, Sun et al. 2014). For the EQ-5D-3L index, 1 represents full health and 0 represents a value equal to being dead. EQ VAS measures the persons health today on a visual analogue scale (VAS) from 0 (worst imaginable health) to 100 (best imaginable health) (EuroQoL 1990, Brooks 1996).

Trial Locations (1)

Unknown

It is an observational study based on the The Swedish Rheumatology Quality Register, Stockholm

All Listed Sponsors
lead

Karolinska Institutet

OTHER

NCT06568029 - Construct Validity and Responsiveness of EQ-5D-3L in Patients With Rheumatic Disease | Biotech Hunter | Biotech Hunter